Review of outcomes used in nutritional trials in Pediatric Critical Care by Ghandvi, K et al.
Review of ou tco m e s  u s e d  in  
n u t ri tion al t ri als  in Pe dia t ric  
Cri tic al Ca r e
Gh a n dvi, K, Valla, F  a n d  Tu m e,  LN
h t t p://dx.doi.o r g/10.1 0 0 2/jpe n.1 7 6 5
Tit l e Review  of ou tco m e s  u s e d  in n u t ri tion al t r i als  in Pedia t ric  
C ri tical Ca r e
Aut h or s Gh a n dvi, K, Valla, F  a n d  Tu m e,  LN
Typ e Article
U RL This  ve r sion  is available  a t :  
h t t p://usir.s alfor d. ac.uk/id/e p rin t/53 4 1 3/
P u bl i s h e d  D a t e 2 0 2 0
U SIR is a  digi t al collec tion  of t h e  r e s e a r c h  ou t p u t  of t h e  U nive r si ty of S alford.  
Whe r e  copyrigh t  p e r mi t s,  full t ex t  m a t e ri al  h eld  in t h e  r e posi to ry is m a d e  
fre ely availabl e  online  a n d  c a n  b e  r e a d ,  dow nloa d e d  a n d  copied  for  no n-
co m m e rcial p riva t e  s t u dy o r  r e s e a r c h  p u r pos e s .  Ple a s e  c h e ck  t h e  m a n u sc rip t  
for  a ny fu r t h e r  copyrig h t  r e s t ric tions.
For  m o r e  info r m a tion,  including  ou r  policy a n d  s u b mission  p roc e d u r e ,  ple a s e




Title: A review of outcomes used in nutritional trials in Pediatric Critical Care 
Kunal R Gadhvi¹, ² BM, BS (Hons), BMedSci, Frédéric V Valla2‚³ MD, MSc, Lyvonne N 
Tume¹, ² RN, PhD. 
¹ Bristol Royal Hospital for Children, Bristol, United Kingdom 
² Faculty of Health and Applied Sciences, The University of the West of England, Glenside 
Campus, Blackberry Hill, Stapleton, Bristol, BS16 1DD, United Kingdom  
³ Pediatric Intensive Care Unit, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, 
CarMEN INSERM UMR 1060, 59 Bd Pinel, 69500 Lyon-Bron, France  
Corresponding author: Kunal Gadhvi 
Address: Paediatric Intensive Care Unit, Paul O’Gorman Building, Bristol Royal Hospital 
for Children, Upper Maudlin Street, Bristol, BS2 8BJ, United Kingdom  
Email: kunalgadhvi@doctors.org.uk; Tel: +61 412 062 374 
Financial disclosure(s): None declared.  
Conflicts of interest: F. Valla is a current consultant for Baxter and Nutricia and has been 
a consultant for Kresenius and Kabi in the past. L. Tume holds a current National Institute 
for Health Research Health Technology Assessment grant in the United Kingdom.  









Clinical relevancy statement: Trials within pediatric intensive care are often single centre 
and underpowered, requiring systematic review with meta-analyses to more generate 
definitive answers to questions. Our review of paediatric nutrition clinical trial outcomes 
indicates a lack of clarity and consistency which can impede this comparison of trials. 
Nutritional outcomes, particularly in the domains of energy targets and feed intolerance 
were not well defined and their definitions inconsistent. The generation of a core outcome 
set will aid future researchers to robustly evaluate nutritional interventions within pediatric 
intensive care.  
 





Background: Generating robust evidence within Pediatric Intensive Care (PIC) can be challenging 
because of low patient numbers and patient heterogeneity. Systematic reviews may overcome small 
study biases but are limited by lack of standardisation in outcome measures and their definition. 
Trials of nutritional interventions in PIC are increasing, thus we wanted to examine the outcome 
measures being used in these trials. 
Objective: To systematically describe outcome measures used when a nutritional intervention has 
been evaluated in a PIC randomized controlled trial.  
Methods: A systematic literature review of all studies involving a PIC trial of a nutritional 
intervention was undertaken from 1 January 1996 until 20 February 2018.  
Results: Thirty-one trials met the criteria and were reviewed. They included a total of 3346 patients 
across all trials. Thirty-nine primary outcomes and 93 secondary outcomes were found. These were 
categorized into PIC-related outcomes (infection, intensive care dependency, organ dysfunction / 
long-term functional and mortality) and nutritional outcomes (energy targets, nutritional 
parameters and feeding tolerance). We found large variation in the outcome measures used. 
Outcome domains of energy targets, feeding tolerance and infection were not adequately defined.  
Conclusions: Large variations in the outcome measures chosen and their definitions exist within PIC 
nutritional trials. Optimal nutritional outcomes for PIC must be agreed and defined, specifically 
domains of nutrition efficiency, nutrition tolerance and non-nutritional PIC outcomes. The next step 
is to conduct an International Delphi study to gain expert consensus and develop a core outcome 





Pediatric Intensive Care (PIC) is a smaller specialty than adult or neonatal intensive care, in 
terms of patient numbers. Many trials within PIC are small, conducted within a single center and 
often underpowered (1). Therefore, there is often a need to undertake systematic reviews to 
generate more robust evidence. However, systematic reviews rely on consistency in outcome 
measures for a meta-analysis (2,3,4). Conducting systematic reviews can be problematic, due to the 
heterogeneity of outcome measures used, with many not able to adequately combine results to 
produce clear answers. The variation in outcome definitions can lead to differences in occurrence 
and estimates of treatment effect, which in systematic review can dilute the real effect (5).  
It is vital that trials are registered and their protocols made publicly available to reduce the 
risk of selective outcome reporting (4). In 2013, a comprehensive review of PIC randomised 
controlled trials (1) analyzed 248 trials from 1879 until April 2013 and found 82% were single 
centre, with mostly small sample sizes. Of these, 63% examined medications, 11% devices and 8% 
were nutritional interventions. Critically, primary outcome measures were identified in only 67% of 
trials, suggesting a need for the agreement around appropriate outcome measures.  
One way to improve consistency in the outcomes reported for an intervention is by 
developing an agreed, standardized collection of specific outcomes, a ‘core outcome set’ (COS) (2). 
A COS promotes the reporting of these outcomes, defined in a consistent manner (as a minimum) in 
future PIC Nutrition trials. The Core Outcome Measures in Effectiveness Trials (COMET) database 
has registered over 300 studies aiming to develop core outcome sets. Within both adult and 
neonatal intensive care work is underway to define a COS for nutritional trials (6), it is now time to 
undertake this in PIC. Currently, knowledge of the outcomes used within PIC nutrition trials is 





Our aim was to systematically describe all outcome measures used when a nutritional 
intervention has been evaluated in a Pediatric Intensive Care (PIC) randomised controlled trial (RCT) 
since 1 January 1996. The study population included all children from birth (>37 weeks’ gestation 
term infants) until the age of 17 years. Trials were targeted because the development of a COS 
relates primarily to randomized controlled studies where an intervention is tested (2).  
A systematic literature search was undertaken of all studies involving a trial of a nutritional 
intervention in PIC from 1 January 1996 until 20 February 2018. Medline (United States National 
Library of Medicine), Excerpta Medica Database (EMBASE), Cumulative Index to Nursing and Allied 
Health Literature (CINAHL), Allied and Complementary Medicine Database (AMED), British Nursing 
Index (BNI), Health Business Elite (HBE), Health Management Information Consortium (HMIC) and 
PsychINFO (American Psychological Association) databases were searched. The search terms  used 
were: 1. Young (adult OR people OR person) 2. (adolescent OR teenage) 3. (pediatric OR paediatric 
OR child OR infant*) 4. (PICU or PIC OR ((critical OR intensive) (care OR unit)) 5. (((enteral OR 
parenteral OR venous OR total OR deliver) ADJ4 nutrition*) OR TPN OR CVN OR PPN OR EN) 6. 1 OR 
2 OR 3. 7. 5 AND 5 AND 6. 8. ((randomized OR randomised) OR RCT OR intervention). 9. 7 AND 8. 
Additionally, trial citations were also extracted from the online database picutrials.net. The study 
was registered with the Core Outcome Measures in Effectiveness Trials (COMET) initiative online 
organization. http://www.comet-initiative.org (7).  
Adult intensive care trials were excluded. Specifically, neonatal intensive care trials were 
also excluded but PIC trials including term newborn infants were analyzed. We also excluded pilot 
studies, to avoid including preliminary interventions where outcomes may have been subject to 
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adaptation prior to a larger study being performed. One reviewer (KG) conducted the search and 
independently screened articles for eligibility using titles and abstracts of papers initially. Full texts 
including supplementary material were then retrieved. The searches and trial selection were then 
reviewed by the two other authors (LT, FV) to confirm inclusion. Figure 1 shows the screening 
process. 
The trial aims, primary and secondary trial outcome measures, together with their 
definitions were extracted using a standardized data extraction tool. The database was reviewed by 
all the authors during the process to confirm trial inclusion and how outcomes measured were 
categorized. The most common outcomes, were defined as primary outcomes reported by more 
than one trial and secondary outcomes reported by at least 5 trials.   
Descriptions of outcome definitions was based on written information provided in the 
published paper. We pragmatically classified outcomes as being adequately or not adequately 
defined. An adequately defined outcome was where the metric was specified and fully described 
together with a measurement time point. Outcomes not described in detail (meeting the criteria 
above) or leaving ambiguous interpretation were designated as ‘not adequately defined’. The 
outcomes were extracted by author KG and reviewed by the other authors LT and FV. 
 
Results  
 The search identified an initial 302 studies (mainly non-nutritional intervention studies) and 
after careful review of 50 studies where a nutritional intervention was investigated in PIC, 31 
randomized PIC nutrition trials met the inclusion criteria and were included in the final analysis (8 – 
38) (Figure 1).  A range of nutritional interventions were studied which included early versus late 
enteral nutrition (26, 30, 33), early versus late parenteral nutrition (8), feeding supplements/ 
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prokinetics/ immune enhancing formulas/ drugs (9, 11, 13, 14, 17, 18, 20, 21, 23, 24, 28, 29, 34, 35, 
37), intermittent versus continuous feeding (16, 22, 38, 25, 27), high protein/high energy/high lipid 
containing feeds (10, 15, 19, 31, 32, 36) and the use of protocolized feeding regimens (12). 
Primary and secondary outcomes were separated into two categories: pediatric intensive 
care and nutritional outcomes respectively (Table 1).  The PIC outcome domains included newly 
acquired infection, markers of inflammation, intensive care dependency or marker of dependency, 
organ dysfunction, long term functional status and mortality.  
Newly acquired infection broken down into specific outcome categories included the 
occurrence or reduced incidence of nosocomial infection (10/20), rates of ventilator associated 
pneumonia (3/20) and sepsis (7/20). Markers of inflammation outcomes specifically included 
changes in cytokine (5/10), C-reactive protein (3/10) and lymphocytes levels (2/10), which were all 
adequately defined (Table 1).  
Outcomes related to intensive care dependency included length of stay (intensive care and / 
or hospital stay) which accounted for 22/38 ICU dependency outcomes and other markers of 
dependency forming the rest, 16/38. These markers included the duration of mechanical ventilation 
most commonly (13/38) together with the number of readmissions to PIC within 48 hours of 
discharge, the duration of haemodynamic support and the proportion of patients receiving renal 
replacement therapy each accounting for a single outcome. 
Organ dysfunction domain outcomes included for example, duration of inotropic support 
(24), markers of liver dysfunction (8), changes in PELOD (Pediatric Logistic Organ Dysfunction) scores 
(14), differences in the PRISM (Pediatric Risk of Mortality) and PIM2 (Pediatric Index of Mortality 2) 
scores respectively (15, 12). Long term functional status outcomes were defined using specific 
scoring systems such as the pediatric overall performance category and pediatric cerebral 
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performance category scores respectively (12). This was the only trial which examined long term 
functional status beyond discharge from hospital.  
The nutritional outcomes included nutrient and energy targets, biochemical or metabolic 
parameters and feeding tolerance. Nutrient and energy target outcomes included both an 
assessment of nutrient and or energy delivery in relation to targets (12, 16, 25, 31, 34, 38) and 
adequacy of nutrient delivery (37) (Table 2).  Outcomes designated as biochemical or metabolic 
parameters included those related to a specific change in a marker; for example, serum zinc levels 
(13), a change in drug requirement (e.g. insulin requirement) (30) or a change in body balance (e.g. 
whole-body protein (15) or nitrogen balance (29) (Table 4). Outcomes related to feeding tolerance 
included complications related to feeding such as vomiting, diarrhoea, high gastric residual volume 
and / or pulmonary aspiration (Table 3).  
The trials used 39 different primary outcome measures, with some trials using multiple 
outcomes  (8, 9, 16, 17, 18, 25, 28, 29, 32, 33, 37, 38). The most frequently reported primary 
outcome measures were ones using a biochemical/metabolic parameter (15/52), infection or 
inflammation outcome (13/52), intensive care dependency (11/52) or nutrient/energy target (8/52). 
Outcomes of feeding tolerance (including adverse events) (4/52) and mortality (3/52) were the least 
common.  
Ninety-three different secondary outcomes measures were used. Intensive care 
dependency, which included length of stay in PIC or hospital and markers of dependency including 
length of mechanical ventilation, hemodynamic support and renal replacement therapy, was the 
most commonly reported secondary outcome measure (27/93). Other outcome measures used 
commonly as secondary outcomes included feeding tolerance (14/93), organ dysfunction / long 
term functional status (13/93) and newly acquired infection or markers of inflammation (13/93). 
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Figure 2 outlines the most common outcomes, highlighting primary outcomes reported by more 
than one trial and secondary outcomes reported by at least 5 trials.   
Outcomes that were not adequately defined, were those outcomes related to nutrient or 
energy targets (1/9), newly acquired infection (13/20) and feeding tolerance (12/18) (Tables 1, 2 
and 3). In all but one trial, when energy targets were used as a primary outcome, their definitions 
were not stated and fully explained with clear measurement time points (Table 2). Specifically, 
outcomes examining the time to reach a daily energy target and the percentage of daily energy 
target achieved lacked an explanation of how the daily energy target was calculated. Others defined 
how this target was calculated, through dietetic assessment of feeding goals with an estimation of 
basal energy expenditure based on patient specific factors (12). Only one trial clearly specified a 
metric, fully describing and defining its primary outcome with a measurement time point, using 
indirect calorimetry on which to base its energy target (31). 
Definitions used for outcomes related to markers of inflammation, intensive care 
dependency, organ dysfunction, long term functional status and nutrition specific biochemical and 
metabolic parameters were better defined (Tables 1 and 4).  
 
Discussion  
This is the first paper to review and report outcome measures used in trials of PIC nutritional 
interventions. Thirty-one trials used a broad range of outcome measures, with 39 primary and 93 
secondary outcomes in total. Thirty-nine percent of trials used more than one primary outcome 
measure. This is not uncommon, with evidence that 20% of trials use more than two primary 
outcome measures and 5% more than five (3). Evidence from adult nutritional trials also shows 
wide variation in the outcome measures used (39).  
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The most frequently measured primary and secondary outcome was intensive care 
dependency, specifically PIC length of stay. There is increasing evidence that inadequate nutrition 
can prolong intensive care stay, increase duration of mechanical ventilation and worsen clinical 
outcomes (40, 41, 42). Nonetheless, its limitation as an outcome measure is the potential variation 
in practice between centers and the impact of multiple confounders. Pediatric Intensive Care Units 
(PICUs) may or may not be mixed high dependency and intensive care, and length of stay may be 
subject to bias because of organizational policies on PIC discharge criteria or ward bed shortages. 
Interestingly, one trial appeared to acknowledge and overcome this outcome limitation by using an 
adjusted duration of ICU dependency primary outcome. This defined discharge from PIC as the time 
when a patient was ready from discharge from PIC, specifically when they no longer required or 
were no longer at risk for needing vital organ support (8).    
Mortality was very rarely used as a primary outcome measure in the PIC nutrition trials we 
evaluated. Mortality continues to fall gradually and its rate in PIC has been <4% in the United 
Kingdom from 2015-2017 (43) in contrast to higher rates in adult intensive care. Given its infrequent 
occurrence, mortality is unlikely to demonstrate statistical significance when used to test a pediatric 
nutritional intervention. 
Apart from infection related outcomes, all other PIC outcomes were well defined. The link 
between malnutrition and infection is well-established (44). Children have low reserves of energy 
and protein sources compared to adults. This, together with their higher metabolic rates puts them 
at greater risk of malnutrition which can predispose them to immunodeficiency. Certainly, there is 
increasing evidence that lower energy intake is associated with adverse outcomes including 
infection and length of intensive care stay in infants with congenital heart disease (41). Infection 
itself is a broad term, and how nosocomial infection and/or sepsis were defined was often not 
stated. Without clear definitions the strength of these infection related outcomes will widely differ 
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between centers potentially reducing the internal validity of a study (39). We found that infection 
outcomes were more clearly defined when an objective measure was chosen, for example, bacterial 
infection rate (28) where a specific microbial pathogen was identified and the number of antibiotic 
free days (13). Definitions were more ambiguous when a more subjective outcome measure was 
used, for example the rate of clinical sepsis (30) which in one study was defined as the presence of 
one of the following: positive blood culture, significant rise in C-reactive protein, thrombocytopenia 
(or fall >150 without surgery), disorientation, ileus, hypotension, hypothermia, metabolic acidosis, 
decreased progression of wound healing, and pulmonary, hepatic or renal failure along with 
systemic antibiotic treatment. If these outcomes are to be robustly evaluated in future meta-
analyses of trials clear and objective definitions of these terms will be essential.  
 We found that longer-term outcome measures, specifically the evaluation of patients after 
discharge from hospital were rarely used in PIC nutrition trials (12). In adult critical care, it is 
increasingly recognized that a nutritional intervention may show a beneficial impact on patients in 
the longer term (39). Core outcomes chosen for PIC will need to consider and reflect this potential 
impact, particularly in light of our higher survival rate of >96% (43). It is important to foresee the 
potential short and long-term outcomes of an intervention being studied.   
 Overall, the nutritional outcomes were less well defined than PIC outcomes. The commonest 
specific nutritional primary outcome was time to reach energy goal. This outcome is logical and easy 
to measure, thus proving an attractive choice for trials. Knowing that children in intensive care often 
fail to achieve even 50% of their predicted energy targets by day 3 (45) justifies this as a useful 
outcome measure. Unintended underfeeding and overfeeding from inaccurate estimations of 
energy requirements in children is associated with poor outcomes (46), with evidence that 
achieving two thirds of target goals was beneficial (47). However, exactly what amount of energy 
intake we should be targeting within differing intensive care illness phases and pathological 
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processes is unknown. Treating all critically ill children as a homogenous group is misleading and 
over simplistic. Failure to account for baseline nutritional status at PIC admission, by lack of any 
validated tool for use in PIC, contributes to the ambiguity.  
Energy target outcomes specifically were often binary in nature (yes/no) without detailing 
energy intake in kilocalories per day or equations that were used to estimate energy intakes. Only 
one trial clearly specified a metric, fully describing and defining its primary outcome with a 
measurement time point using indirect calorimetry on which to base its energy target (31, Table 2). 
Although indirect calorimetry is recommended as the gold standard for assessing energy 
expenditure after the acute phase of illness (46), it is not widely available or indeed feasible in some 
PIC patients (48).  
Biochemical and metabolic parameters as a group within the nutritional outcomes were 
adequately defined (Table 4). Specific blood markers related to the trial intervention and 
measurements of protein, fat and glucose metabolism had a specified metric, fully described 
together with a measurement time point. Objective measurements as used for these outcomes are 
likely to make well defined outcomes for nutritional trials in the future. A core outcome set may not 
need to include very specific outcomes such as these but any nutritional trial could add outcome 
measures such as these tailored to the intervention being tested.  
  One of the least common primary outcomes used was feeding tolerance (including adverse 
events) (4/53). Rates of feeding complications or adverse event outcomes were used more 
commonly as secondary outcomes (14/93). Specific feeding complications varied between trials, as 
did their definitions (Table 3). This variability led to complications often being combined when their 
individual occurrence rates may have been significantly different, for example vomiting, and 
pulmonary aspiration (25, 38).  
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Recent evidence shows that feed intolerance is the commonest cause of stopping feeds (40). 
In the reviewed trials, when gastric residual volume (GRV) was used to define feed intolerance, 
varying thresholds were used (16, 22, Table 3). The assessment of GRV remains a controversial issue 
without any evidence to support the practice or to know what maximal volume or level is significant 
(40, 49, 50). Despite this, feed intolerance based upon GRV is known to be the most common cited 
reason amongst PIC healthcare professionals for stopping or withholding enteral nutrition (40). 
However, heterogeneity in its definition makes the comparison of studies difficult and meta-analysis 
impossible (39, 51) and this is probably why it was rarely used. A pragmatic consistent agreement 
on the definition of feed intolerance is likely to aid its use as an outcome measure in future 
nutrition trials.        
 Without comprehensive definitions, specific nutritional outcomes are likely to be subjective 
and open to bias. Despite this the optimal nutritional support strategy is still not established (52); 
the timing, dosing and combination of nutrients delivered to critically ill children requires robustly 
designed studies. These should take into account patient heterogeneity (in terms of primary 
diagnosis, nutritional status, etc), their metabolic state (hypo / hypermetabolism) and include well 
defined outcome measures.  
 Adherence to recent guidance for trial protocols (53) would help researchers provide clear, 
transparent and clearly defined study outcomes. Pediatric trials are known for their challenges 
which include small patient numbers, differences in pathophysiology, patient age and physiological 
states, to add to difficulties in recruitment (54).  Often these trials, as a result, are underpowered to 
show a treatment effect. Reporting a set of core outcomes would reduce the variability 
encountered when comparing trials and pooling their results.  
There are some limitations that warrant mentioning, our search was limited to randomized 
controlled trials and therefore we were not comprehensive in evaluating all outcomes used in 
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nutritional studies. Nonetheless, we did review trials back to 1996 to give a detailed overview of the 
outcomes previously used to evaluate a PIC nutritional intervention within trials.   
The next step following this review is to undertake an international Delphi study to agree 
COS for trials of nutritional interventions in PIC. Experts from around the world would vote on a 
clear definition of non-nutritional outcomes and nutritional outcomes to be used in nutritional 
intervention trials. Importantly the nutritional outcomes could also be used in non-nutritional 
intervention trials that may also want to explore these outcomes. Once a COS is agreed and 
published, this will be actively disseminated. This should ultimately enhance the consistency and 
clarity of reporting of outcomes both in randomized trials and all studies of nutritional interventions 
in the PICU population in future trials.  
 
Conclusion  
Large variation in outcome measures and their definitions exists within pediatric critical care 
nutritional trials. If nutritional interventions are to impact outcomes of critical illness, it is now 
essential that they are defined consistently and objectively. Optimal nutritional outcomes for PIC 
should now be agreed and defined. Ideally, these would include outcome domains of nutrition 
efficiency, nutrition tolerance and non-nutritional PIC outcomes. The priority of each domain will 
depend on the research question and the nutritional intervention being tested. The next step is to 
conduct an International Delphi study to gain expert consensus for a standardized core outcome set 
to be reported in all future pediatric nutrition trials. Importantly, as others have mentioned (2,5), 
this outcome set would not be prohibitive to the inclusion of other specific outcomes related to the 
intervention being tested. It would rather act as an essential core baseline to aid future worldwide 
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